Head to head

Splendor X vs Clarity II (2026)

Compare purchase costs, running costs and the evidence behind each device.

Read the comparison overview

Purchase cost: Catalog new-price ranges: Splendor X, $130k–$165k; Clarity II, $100k–$140k. Check the source notes and request current quotes.
Practice fit: Both are listed under dual-wavelength laser. Check each model’s US regulatory status and labeled indications for your intended use.

Device A

Dual-wavelength laser

View full device profile →

Device B

Dual-wavelength laser

View full device profile →

Price comparison

Price comparison: Lumenis Splendor X vs Lutronic Clarity II
Attribute	Lumenis Splendor X	Lutronic Clarity II
New price range	$130k–$165kSource not documented	$100k–$140kSource not documented
Used asking range	$70k–$110kSource not documented	$60k–$90kSource not documented
Payback calculator	View ROI calculator	View ROI calculator
Next step

New price range

Lumenis Splendor X: $130k–$165kSource not documented
Lutronic Clarity II: $100k–$140kSource not documented

Used asking range

Lumenis Splendor X: $70k–$110kSource not documented
Lutronic Clarity II: $60k–$90kSource not documented

Payback calculator

Lumenis Splendor X: View ROI calculator
Lutronic Clarity II: View ROI calculator

Next step

Lumenis Splendor X

Lutronic Clarity II

Consumable economics

Consumable economics: Lumenis Splendor X vs Lutronic Clarity II
Attribute	Lumenis Splendor X	Lutronic Clarity II
Consumable cost / lock-in	No per-treatment disposable. The recurring cost is wear parts — handpiece lenses, flashlamp, protective windows, ceramic reflector, Nd:YAG and alexandrite rods, fibre window. Not published — Lumenis does not publish US wear-part pricing and the figures previously shown carried no dated source.	Config-dependent: 510(k) K183566 lists cooling by Chilled Air or by the Intelligent Cryogen Device (ICD). Air-cooled units have no cryogen consumable; ICD units consume cryogen cans.
Service cost	Not published	Not published

Consumable cost / lock-in

Lumenis Splendor X: No per-treatment disposable. The recurring cost is wear parts — handpiece lenses, flashlamp, protective windows, ceramic reflector, Nd:YAG and alexandrite rods, fibre window. Not published — Lumenis does not publish US wear-part pricing and the figures previously shown carried no dated source.
Lutronic Clarity II: Config-dependent: 510(k) K183566 lists cooling by Chilled Air or by the Intelligent Cryogen Device (ICD). Air-cooled units have no cryogen consumable; ICD units consume cryogen cans.

Service cost

Lumenis Splendor X: Not published
Lutronic Clarity II: Not published

FDA clearance

FDA clearance: Lumenis Splendor X vs Lutronic Clarity II
Attribute	Lumenis Splendor X	Lutronic Clarity II
FDA status & indication	FDA ClearedK241407, K243445 Read FDA indication wording “The Nd:YAG 1064 Laser is intended for: • Removal of unwanted hair, for stable long term or permanent hair reduction and for treatment of Pseudofolliculitis barbae (PFB). Permanent hair reduction is defined as the long-term, stable reduction in the number of hairs regrowing when measured at 6, 9, and 12 months after the completion of a treatment regime. The lasers are indicated on all skin types, such as Fitzpatrick I-VI, including tanned skin. • Photocoagulation and hemostasis of benign pigmented and vascular lesions such as, but not limited to, port-wine stains, hemangioma, warts, telangiectasia, rosacea, venous lake, leg veins and spider veins. • Coagulation and hemostasis of soft tissue. • Treatment of benign pigmented lesions such as, but not limited to, lentigos (age spots), solar lentigos (sunspots), cafe au lait macules, seborrheic keratosis, nevi, chloasma, verrucae, skin tags, keratosis, tattoos (significant reduction in the intensity of black and/or blue-black tattoos) and plaques. The laser is indicated for benign pigmented lesions to reduce lesion size, for patients with benign lesions that would potentially benefit from aggressive treatment, and for patients with benign lesions that have not responded to other laser treatments. • Reduction of red pigmentation in hypertrophic and keloid scars where vascularity is an integral part of the scar. • Treatment of wrinkles. • Temporary increase of clear nail in patients with onychomycosis (e.g., dermatophytes, Trichophyton rubrum and T. mentagrophytes, and/or yeast Candida Albicans, etc.). The Alexandrite 755 laser is intended for: • Temporary hair reduction. • Stable long-term or permanent hair reduction through selective targeting of melanin in hair follicles. Permanent hair reduction is defined as the long-term, stable reduction in the number of hairs regrowing when measured at 6, 9, and 12 months after the completion of a treatment regime. On all skin types, such as Fitzpatrick I – VI, including tanned skin. • Treatment of benign pigmented lesions. • Treatment of wrinkles. • Photocoagulation of dermatological benign vascular lesions (such as port-wine stains, hemangiomas, telangiectasias).”	FDA ClearedK183566 Read FDA indication wording “755 nm The CLARITY II 755 nm Laser System is indicated for temporary hair reduction and stable long-term or permanent reduction through selective targeting of melanin in hair follicles. Permanent hair reduction is defined as the long-term, stable reduction in the number of hairs regrowing when measured at 6, 9, and 12 months after the completion of a treatment regime on all skin types (Fitzpatrick 1-VI) including tanned skin. The 755 nm laser is also indicated for treatment of benign pigmented lesions, vascular lesions and wrinkles. 1064 nm The CLARITY II 1064 nm Laser System is indicated for stable long term or permanent hair reduction and for treatment of PFB (Pseudofolliculitis Barbae) on all skin types, Fitzpatrick I – VI, including tanned skin. Permanent hair reduction is defined as the long-term, stable reduction in the number of hairs regrowing when measured at 6, 9, and 12 months after the completion of a treatment regime. The 1064 nm laser is also indicated for coagulation and hemostasis of soft tissue, for hemostasis of vascular lesions such as but not limited to port wine stains, hemangiomna, warts, telangiectasia, rosacea, venus lake, leg veins and spider veins. The 1064 nm laser system is also indicated for the treatment of benign pigmented lesions such as, but not limited to, lentigos (age spots), solar lentigos (sun spots), café au lait macules, seborrheic keratoses, nevi, chloasma, verrucae, skin tags, keratoses, (significant reduction in the intensity of black and/or blue- black tattoos) and plaques. The 1064 nm Laser is also indicated for the treatment of wrinkles such as, but not limited to, periocular and perioral wrinkles.”

FDA status & indication

Lumenis Splendor X: FDA ClearedK241407, K243445
Read FDA indication wording
“The Nd:YAG 1064 Laser is intended for: • Removal of unwanted hair, for stable long term or permanent hair reduction and for treatment of Pseudofolliculitis barbae (PFB). Permanent hair reduction is defined as the long-term, stable reduction in the number of hairs regrowing when measured at 6, 9, and 12 months after the completion of a treatment regime. The lasers are indicated on all skin types, such as Fitzpatrick I-VI, including tanned skin. • Photocoagulation and hemostasis of benign pigmented and vascular lesions such as, but not limited to, port-wine stains, hemangioma, warts, telangiectasia, rosacea, venous lake, leg veins and spider veins. • Coagulation and hemostasis of soft tissue. • Treatment of benign pigmented lesions such as, but not limited to, lentigos (age spots), solar lentigos (sunspots), cafe au lait macules, seborrheic keratosis, nevi, chloasma, verrucae, skin tags, keratosis, tattoos (significant reduction in the intensity of black and/or blue-black tattoos) and plaques. The laser is indicated for benign pigmented lesions to reduce lesion size, for patients with benign lesions that would potentially benefit from aggressive treatment, and for patients with benign lesions that have not responded to other laser treatments. • Reduction of red pigmentation in hypertrophic and keloid scars where vascularity is an integral part of the scar. • Treatment of wrinkles. • Temporary increase of clear nail in patients with onychomycosis (e.g., dermatophytes, Trichophyton rubrum and T. mentagrophytes, and/or yeast Candida Albicans, etc.). The Alexandrite 755 laser is intended for: • Temporary hair reduction. • Stable long-term or permanent hair reduction through selective targeting of melanin in hair follicles. Permanent hair reduction is defined as the long-term, stable reduction in the number of hairs regrowing when measured at 6, 9, and 12 months after the completion of a treatment regime. On all skin types, such as Fitzpatrick I – VI, including tanned skin. • Treatment of benign pigmented lesions. • Treatment of wrinkles. • Photocoagulation of dermatological benign vascular lesions (such as port-wine stains, hemangiomas, telangiectasias).”
Lutronic Clarity II: FDA ClearedK183566
Read FDA indication wording
“755 nm The CLARITY II 755 nm Laser System is indicated for temporary hair reduction and stable long-term or permanent reduction through selective targeting of melanin in hair follicles. Permanent hair reduction is defined as the long-term, stable reduction in the number of hairs regrowing when measured at 6, 9, and 12 months after the completion of a treatment regime on all skin types (Fitzpatrick 1-VI) including tanned skin. The 755 nm laser is also indicated for treatment of benign pigmented lesions, vascular lesions and wrinkles. 1064 nm The CLARITY II 1064 nm Laser System is indicated for stable long term or permanent hair reduction and for treatment of PFB (Pseudofolliculitis Barbae) on all skin types, Fitzpatrick I – VI, including tanned skin. Permanent hair reduction is defined as the long-term, stable reduction in the number of hairs regrowing when measured at 6, 9, and 12 months after the completion of a treatment regime. The 1064 nm laser is also indicated for coagulation and hemostasis of soft tissue, for hemostasis of vascular lesions such as but not limited to port wine stains, hemangiomna, warts, telangiectasia, rosacea, venus lake, leg veins and spider veins. The 1064 nm laser system is also indicated for the treatment of benign pigmented lesions such as, but not limited to, lentigos (age spots), solar lentigos (sun spots), café au lait macules, seborrheic keratoses, nevi, chloasma, verrucae, skin tags, keratoses, (significant reduction in the intensity of black and/or blue- black tattoos) and plaques. The 1064 nm Laser is also indicated for the treatment of wrinkles such as, but not limited to, periocular and perioral wrinkles.”

Which chains run each

Which chains run each: Lumenis Splendor X vs Lutronic Clarity II
Attribute	Lumenis Splendor X	Lutronic Clarity II
Chain adoption	0 recorded pairings	1 recorded pairing
Chains using it	—	Foxy Box Laser + Wax Bar(Confirmed)
Approved reviews	0	0

Chain adoption

Lumenis Splendor X: 0 recorded pairings
Lutronic Clarity II: 1 recorded pairing

Chains using it

Lumenis Splendor X: —
Lutronic Clarity II: Foxy Box Laser + Wax Bar(Confirmed)

Approved reviews

Lumenis Splendor X: 0
Lutronic Clarity II: 0

Specs and platform

Specs and platform: Lumenis Splendor X vs Lutronic Clarity II
Attribute	Lumenis Splendor X	Lutronic Clarity II
Manufacturer	Lumenis	Lutronic
Built by (OEM)	Lumenis Be Ltd.	Lutronic Corporation
Category	Dual-wavelength laser	Dual-wavelength laser
Technology	755+1064nm BLEND X square spot	755/1064nm, IntelliTrak speed sensing
Launch year	2018	2021
Status	Current	Current
Manufacturer source record	No linked source on file.	No linked source on file.

Manufacturer

Lumenis Splendor X: Lumenis
Lutronic Clarity II: Lutronic

Built by (OEM)

Lumenis Splendor X: Lumenis Be Ltd.
Lutronic Clarity II: Lutronic Corporation

Current alternatives

Current catalog models in related categories. Confirm availability and configuration with the supplier.

Cutera Excel HR

Dual-wavelength laser

New: $95k–$135k

Quanta System Thunder (MT)

Dual-wavelength laser

New: $110k–$150k

Quanta System Duetto MT / MT Evo

Dual-wavelength laser

New: $80k–$120k

Get a free recommendation Browse by goal

Device and company names are trademarks of their respective owners. The Aesthetic Index is not affiliated with or endorsed by any manufacturer, distributor or lender named here, except as disclosed. Price figures are references, not current offers. Check each device’s source notes. Not medical, legal or regulatory advice.